IRONWOOD PHARMACEUTICALS INC (IRWD) Stock News

Let's take a look at the stocks that are in motion in today's session.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Top stock movements in today's session.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

There are notable gap-ups and gap-downs in today's session.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Curious about the stocks that are showing activity after the closing bell on Wednesday?

After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Earnings Preview: Ironwood Pharmaceuticals

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ironwood Pharmaceuticals (NASDAQ:IRWD) just reported results for the second qua...

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Ironwood Pharmaceuticals Reports First Quarter 2024 Results

Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference

Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks

As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid.

Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call

Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.